Table 6 Risk factor analysis of progression in 1 year after RNU
Variables | No progression n = 65 (%) | Progression n = 5 (%) | p-value | |
|---|---|---|---|---|
Age (years) | ≥ 70 | 42 (64.6) | 5 (100.0) | 0.1639 |
Gender | Male | 48 (73.8) | 5 (100.0) | 0.3255 |
Laterality | Right | 33 (50.8) | 3 (60.0) | 1.0000 |
Location of main tumor | Ureter | 28 (43.1) | 3 (60.0) | 0.6489 |
Hydronephrosis | Yes | 20 (30.8) | 2 (40.0) | 0.6463 |
Urine cytology | Positive | 31 (47.7) | 0 (0.0) | 0.0616 |
Urinary BTA | Positive | 27 (41.5) | 1 (20.0) | 0.6415 |
Urinary NMP22 | Positive | 32 (49.2) | 1 (20.0) | 0.3608 |
Diagnostic ureteroscopic biopsy | Yes | 21 (32.3) | 2 (40.0) | 1.0000 |
Multifocality | Multiple | 9 (13.8) | 0 (0.0) | 1.0000 |
Tumor size (cm) | ≥ 3 | 28 (43.1) | 4 (80.0) | 0.1710 |
Pathological T stage | ≥ 3 | 20 (30.8) | 4 (80.0) | 0.0439* |
Grade | 3 | 30 (46.2) | 4 (80.0) | 0.1921 |
LVI | Positive | 15 (23.1) | 2 (40.0) | 0.5887 |
INF | b, c | 45 (69.2) | 5 (100.0) | 0.3117 |
Pneumoretroperitoneum time (min) | ≥ 210 | 30 (46.2) | 2 (40.0) | 1.0000 |
Total operating time (min) | ≥ 360 | 29 (44.6) | 2 (40.0) | 1.0000 |
ASC | Yes | 20 (30.8) | 3 (60.0) | 0.3221 |